Vaxart
VXRT
$0.73
Share price
-2.68%
Change (1 day)
-16.22%
Change (1 year)
Categories
Vaxart (VXRT) - Total debt
Total debt on the balance sheet as of December 2023 : $20.08 M
According to Vaxart's latest financial reports the company's total debt is $20.08 M. A company’s total debt is the sum of all current and non-current debts.
Vaxart - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $20.08 M | -7.45% |
| 2022-12-31 | $21.7 M | 66.86% |
| 2021-12-31 | $13 M | 80.47% |
| 2020-12-31 | $7.2 M | 211.63% |
| 2019-12-31 | $2.31 M | -35.95% |
| 2018-12-31 | $3.61 M | |
| 2017-06-30 | $0.3 M | -57.14% |
| 2016-06-30 | $0.7 M | -30% |
| 2015-06-30 | $1 M | |
| 2010-12-31 | $N/A | -100% |
| 2009-12-31 | $5.95 M | -60.85% |
| 2008-12-31 | $15.2 M | -78.81% |
| 2007-12-31 | $71.73 M | -34.55% |
| 2006-12-31 | $0.10 B | -0% |
| 2005-12-31 | $0.10 B | 359.68% |
| 2004-12-31 | $23.84 M | -12.96% |
| 2003-12-31 | $27.39 M | |
| 2001-12-31 | $78.5 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -95.99% | Bahamas |
 NRC Health
NRC | $36.68 M | 82.62% | 🇺🇸 USA |